EMD-18657

Single-particle
3.5 Å
EMD-18657 Deposition: 14/10/2023
Map released: 06/12/2023
Last modified: 02/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-18657

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8qu8 summary report (pdf.gz) Map-8qu8 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

PROTAC-mediated complex of KRAS with VHL/Elongin-B/Elongin-C/Cullin-2/Rbx1

EMD-18657

Single-particle
3.5 Å
EMD-18657 Deposition: 14/10/2023
Map released: 06/12/2023
Last modified: 02/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: KRAS/ACBI3/VHL/EloB/EloC/Cul2/Rbx1
Fitted models: 8qu8

Deposition Authors: Fischer G , Peter D , Arce-Solano S
Targeting cancer with small-molecule pan-KRAS degraders.
PUBMED: 39298590
DOI: doi:10.1126/science.adm8684
ISSN: 1095-9203
ASTM: SCIEAS
Grant Support: